Rising Prevalence of Neutropenia-Related Conditions Propels
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive...
Source: globenewswire.com
Beyondspring Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Beyondspring Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Beyondspring Pharmaceuticals Today - Breaking & Trending Today
Global Neutropenia Market to Reach $5.77 Billion by 2028 with a CAGR of 6.2%: Growing Prevalence of Leukemia Drives Demand
/PRNewswire/ -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and...
Source: prnewswire.com
2030 | Neutropenia Biologic Drug Treatment Market Research
Jun 19, 2023 (The Expresswire) -- "Neutropenia Biologic Drug Treatment Market" Insights 2023 By Types (, By Drug Type, Filgrastim, Pegfilgrastim,...
Source: marketwatch.com
Elranatamab Elicits Responses in Relapsed/Refractory Myeloma After Prior BCMA-directed Therapy
Treatment with elranatamab monotherapy produced early, deep, and durable responses in patients with relapsed/refractory multiple myeloma who received a prior BCMA-directed therapy, according to a pooled analysis of the MagnetisMM-1, MagnetisMM-2, MagnetisMM-3, and MagnetisMM-9 trials.
Source: onclive.com
Morningstar's Best- and Worst-Performing Stocks: 2022
Chinese stocks rebound, energy stocks such as Occidental surge, while Farfetch and other internet retailers plunge.
Source: morningstar.com